中国人兽共患病学报
中國人獸共患病學報
중국인수공환병학보
CHINESE JOURNAL OF ZOONOSES
2009年
7期
630-635
,共6页
潘渭涓%陈祥%王晓泉%丛秋霞%潘志明%高崧%焦新安
潘渭涓%陳祥%王曉泉%叢鞦霞%潘誌明%高崧%焦新安
반위연%진상%왕효천%총추하%반지명%고숭%초신안
禽%大肠杆菌%沙门菌%喹诺酮%耐药性%交叉耐药
禽%大腸桿菌%沙門菌%喹諾酮%耐藥性%交扠耐藥
금%대장간균%사문균%규낙동%내약성%교차내약
avian%Escherchia coli%Salmonella%quinolone%antimicrobial resistance%cross-resistance
目的 了解上世纪90年代以来我国部分地区禽源大肠杆菌和沙门菌分离株对1-4代喹诺酮类药物耐药情况.方法 血清型采用常规的凝集试验进行测定;药敏纸片试验采用CLSI(clinical and laboratory standards institute)推荐的K-B药敏纸片法.结果 344株禽源大肠杆菌分离株覆盖了27个血清型,其中O78、O2、O1和O18血清型菌株分别有141、47、27和22株,共237株,占定型菌株的68.90%;224株禽源沙门菌经血清型鉴定均为鸡白痢沙门菌.1993-1999年禽源大肠杆菌分离株仅对萘啶酸的耐药率超过60%(62.43%,113/181);2000-2008年禽源大肠杆菌分离株对1-3代9种喹诺酮类药物的耐药率均超过60%;禽源沙门菌从2000年起开始出现喹诺酮类耐药菌株,2000-2008年分离到的沙门菌对萘啶酸的耐药率达到了83.74%,但对其它喹诺酮类抗生素的耐药率相对较低.结论 近20年来,我国禽源大肠杆菌和沙门菌对喹诺酮类药物的耐药性不断上升,10种喹诺酮类药物之间存在着不同程度的交叉耐药性,且禽源大肠杆菌比沙门菌对喹诺酮类药物的耐药性更为严重,交叉耐药情况亦更为复杂.
目的 瞭解上世紀90年代以來我國部分地區禽源大腸桿菌和沙門菌分離株對1-4代喹諾酮類藥物耐藥情況.方法 血清型採用常規的凝集試驗進行測定;藥敏紙片試驗採用CLSI(clinical and laboratory standards institute)推薦的K-B藥敏紙片法.結果 344株禽源大腸桿菌分離株覆蓋瞭27箇血清型,其中O78、O2、O1和O18血清型菌株分彆有141、47、27和22株,共237株,佔定型菌株的68.90%;224株禽源沙門菌經血清型鑒定均為鷄白痢沙門菌.1993-1999年禽源大腸桿菌分離株僅對萘啶痠的耐藥率超過60%(62.43%,113/181);2000-2008年禽源大腸桿菌分離株對1-3代9種喹諾酮類藥物的耐藥率均超過60%;禽源沙門菌從2000年起開始齣現喹諾酮類耐藥菌株,2000-2008年分離到的沙門菌對萘啶痠的耐藥率達到瞭83.74%,但對其它喹諾酮類抗生素的耐藥率相對較低.結論 近20年來,我國禽源大腸桿菌和沙門菌對喹諾酮類藥物的耐藥性不斷上升,10種喹諾酮類藥物之間存在著不同程度的交扠耐藥性,且禽源大腸桿菌比沙門菌對喹諾酮類藥物的耐藥性更為嚴重,交扠耐藥情況亦更為複雜.
목적 료해상세기90년대이래아국부분지구금원대장간균화사문균분리주대1-4대규낙동류약물내약정황.방법 혈청형채용상규적응집시험진행측정;약민지편시험채용CLSI(clinical and laboratory standards institute)추천적K-B약민지편법.결과 344주금원대장간균분리주복개료27개혈청형,기중O78、O2、O1화O18혈청형균주분별유141、47、27화22주,공237주,점정형균주적68.90%;224주금원사문균경혈청형감정균위계백리사문균.1993-1999년금원대장간균분리주부대내정산적내약솔초과60%(62.43%,113/181);2000-2008년금원대장간균분리주대1-3대9충규낙동류약물적내약솔균초과60%;금원사문균종2000년기개시출현규낙동류내약균주,2000-2008년분리도적사문균대내정산적내약솔체도료83.74%,단대기타규낙동류항생소적내약솔상대교저.결론 근20년래,아국금원대장간균화사문균대규낙동류약물적내약성불단상승,10충규낙동류약물지간존재착불동정도적교차내약성,차금원대장간균비사문균대규낙동류약물적내약성경위엄중,교차내약정황역경위복잡.
Quinolones are broad-spectrum antibacterial agents used in human and veterinary medicine, and their extensive use have been associated with a rise of the quinolone resistance. In the present study, the quinolone resistance of avian E.coli and Salmonella isolates was evaluated and compared, in which 344 avian E.coli and 224 Salmonella isolates from 1990s were serogrouped with antisera and thc antimicrobial susceptibility test to 10 quinolones was carried out by using the Kirby-Bauer method recommended by Clinical and Laboratory Standards Institute (CLSI). It was demonstrated that the 344 isolates of avian E.coli distributed in 27 serogroups and 68.90% (237/344) of the isolates belonged to four O-serogroups: i.e. O1, O2, O18, O78, and the 224 isolates of avian Salmonella were all determined to be Salmonella pullorum. The drug-resistance rate of avian E. coli isolates to nalicixic acid from 1993-1999 was more than 60%(64.43%,131/181), whereas those of isolates to 9 antibiotics from 2000-2008 had a drug-resistance rates of more than 60%, namely,nalicixic acid(92.02%), fleroxacin(79.75%), pipemidic acid(79.14%), enrofloxacin(78.53%), enoxacin(76.07%), lomenfloxacin(74.85%), ciprofloxacin(69.33%), norfloxacin(63.80%) and ofloxacin(61.35%). For the 4 O-serogroups of the avian E.coli isolates, the drug-resistance rates of more than 50% to antimicrobials were as follows: O78 isolates to 7 antimicrobials;O18 isolates to 5 antimicrobials, and O1 and O2 isolates just to 3 antimicrobials. The quinolone resistance of Salmonella isolates was much lower than E.coli, in which 101 salmonella isolates from 1993-1999 were all susceptible to quinolones. Nalicixic acid resistance of salmonella isolate firstly appeared in 2000, and the drug-resistance rate of salmonella isolates from 2000-2008 was found to be more than 60% for nalicixic acid(83.74%), but those to other quinolones were comparatively lower. These results indicated that the quinolone resistance of avian E.coli and salmonella were increasing in the past two decads because of the over-use of antibiotics.